In Brief: FDA drug/biologic review reforms
FDA drug/biologic review reforms: FDA selected as one of 99 government semifinalists in the 1997 Innovations in American Government Awards for its improvement in review times. Sponsored by the Ford Foundation and Harvard's John F. Kennedy School of Government, the award had 1,540 applicants. Ten winners will be selected, each of whom will receive $100,000...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth